Ballentine Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,788
Closed -$301K 699
2023
Q3
$301K Buy
+13,788
New +$288K 0.01% 443
2023
Q2
Sell
-12,615
Closed -$245K 613
2023
Q1
$245K Buy
12,615
+211
+2% +$3.68K 0.01% 464
2022
Q4
$199K Buy
12,404
+340
+3% +$5.54K 0.01% 469
2022
Q3
$189K Sell
12,064
-84
-0.7% -$1.62K 0.01% 443
2022
Q2
$253K Sell
12,148
-6,028
-33% -$124K 0.01% 351
2022
Q1
$412K Buy
18,176
+173
+1% +$3.38K 0.01% 292
2021
Q4
$329K Hold
18,003
0.01% 352
2021
Q3
$381K Sell
18,003
-208
-1% -$3.86K 0.01% 283
2021
Q2
$332K Sell
18,211
-273
-1% -$6.37K 0.01% 305
2021
Q1
$418K Buy
18,484
+311
+2% +$7.02K 0.02% 247
2020
Q4
$365K Buy
18,173
+170
+0.9% +$3.56K 0.01% 248
2020
Q3
$440K Hold
18,003
0.02% 218
2020
Q2
$428K Sell
18,003
-27,919
-61% -$647K 0.02% 222
2020
Q1
$791K Buy
45,922
+27,996
+156% +$512K 0.05% 144
2019
Q4
$316K Buy
+17,926
New +$304K 0.01% 293
2018
Q4
Sell
-10,000
Closed -$177K 357
2018
Q3
$177K Hold
10,000
0.01% 343
2018
Q2
$215K Hold
10,000
0.01% 308
2018
Q1
$222K Hold
10,000
0.01% 310
2017
Q4
$304K Sell
10,000
-499
-5% -$13.3K 0.02% 261
2017
Q3
$254K Sell
10,499
-5,633
-35% -$150K 0.01% 302
2017
Q2
$443K Buy
+16,132
New +$341K 0.03% 215

Other funds holding EXEL

Ballentine Partners's EXEL Position: Q4 2023 in Review

Ballentine Partners sold out of Exelixis (EXEL) in Q4 2023, closing a stake of 13,788 shares — an estimated $301K sold.

Ballentine Partners first reported a position in EXEL in Q2 2017 and held it in 21 quarters. The position peaked at $791K in Q1 2020. 425 funds tracked by Wall St. Rank hold EXEL as of Q4 2023.

  • Ballentine Partners reported no remaining Exelixis position as of Q4 2023 after selling out during the quarter.
  • Ballentine Partners sold 13,788 Exelixis shares in Q4 2023, an estimated $301K.
  • Ballentine Partners first reported a position in Exelixis in Q2 2017 and held it in 21 quarters.
  • Ballentine Partners's Exelixis position peaked at $791K in Q1 2020.
  • 425 funds tracked by Wall St. Rank held Exelixis as of Q4 2023.

Based on Ballentine Partners's 13F filing for Q4 2023, filed 23 Jan 2024.